Intervas Device (NRIFP Beijing)
- User: Male
- Hormonal: Non-Hormonal
-
Delivery type:
- Vas Deferens
-
Intended Duration:
- Permanent
- Long-Acting
- Development Stage: Phase II
- Developer(s)/researcher(s): National Research Institute for Family Planning in Beijing
Details
-
Mechanism of Action:
- Vas Deferens Occlusion
- Inhibition of Sperm Motility
- Inhibition of Sperm Capacitation
- Inactive Materials: Polyurethane, Barium Sulphate
- Regimen: Single Placement
- MPT: Not Potential MPT
Product Status
No public indication of development after 2014
History
Limited public, verifiable information. The device may have progressed to or through regulatory approval in China, but no credible online sources confirm.